# MTD acquires Ypsomed's pen needle and BGM businesses

MTD (Medical Technology and Devices) announced the acquisition of Ypsomed's pen needle and blood glucose monitoring (BGM) businesses. The deal strengthens MTD's position in diabetes care and is expected to close in summer 2024.

- Type: Acquisition
- Announced: 2024-03-27
- Status: announced
- Products: pen needles, blood glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (target)
- [MTD](https://endata.com/companies/57329.md) (acquirer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/mtd-acquires-ypsomeds-pen-needle-and-bgm-businesses-strengthening-its-leading-position-in-diabetes-care-302100976.html), 2024-03-27: "MTD announces the acquisition of Ypsomed's pen needle and blood glucose monitoring (BGM) businesses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.